2025-12-19 - Analysis Report
Here's a report analyzing C3.ai Inc. (AI) based on the provided data.

**1) Return Rate Comparison and Analysis**

*   **Company Overview:** C3.ai Inc. is an enterprise AI software provider, delivering solutions for various industries.
*   **Return Rates:**
    *   AI Cumulative Return: -45.30%
    *   VOO (S&P 500) Cumulative Return: 47.71%
    *   Divergence: -93.01%
    *   Relative Divergence: 1.9 (Indicates the divergence is near its historical low)

*   **Analysis:** C3.ai has significantly underperformed the S&P 500 (VOO) over the period. The -93.01% divergence indicates a substantial difference in returns, with AI lagging far behind. The relative divergence of 1.9 suggests this underperformance is near the worst it has been historically.

*   **Alpha, Beta Analysis:**

    | Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
    |------------|------|------|-------|------|-------|
    | 2020-2022  | -64.0% | 77.9% | -40.0% | -0.1 | 1.6 |
    | 2021-2023  | 6.0% | 82.8% | 5.0% | -0.0 | 4.0 |
    | 2022-2024  | 59.0% | 82.8% | 39.0% | 0.0 | 4.8 |
    | 2023-2025  | -8.0% | 82.8% | -71.0% | 0.0 | 1.9 |

    *   The table shows periods of high volatility (high MDD) and inconsistent performance.
    *   Alpha values fluctuate significantly, indicating the company's performance relative to the market varies greatly. The recent -71% alpha suggests very poor relative performance.
    *   Beta is close to 0, suggesting the stock is uncorrelated with the market.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** $13.77
*   **Previous Close:** $14.05
*   **Change:** -1.99%
*   **Simple Moving Averages:**
    *   5-day SMA: $14.45
    *   20-day SMA: $14.62
    *   60-day SMA: $16.28

*   **Analysis:** The stock price is currently below all three moving averages, suggesting a short-term downtrend. The recent price decrease of 1.99% signals continued negative momentum.

**3) Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 42.20 (Neutral, neither overbought nor oversold)
*   **PPO:** -0.20 (Slightly bearish)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (69 shares - Very Safe - MRI:0.90) Monthly invest 1.6% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) Relative Divergence Change:** -3.2 (Downward Trend)
*   **Expected Return (%):** -803.9%

*   **Analysis:**
    *   The MRI suggests a medium level of investment risk.
    *   The RSI is neutral.
    *   The negative PPO reinforces the short-term downtrend.
    *   The large negative expected return is a significant red flag.
    *   The negative change in relative divergence confirms short-term underperformance against the comparison stock.

**4) Recent News & Significant Events (Yahoo Finance)**

*   **Key Themes:**
    *   AI stock volatility and uncertainty ("AI anxiety returns," "AI trade may not be back for good").
    *   Micron's positive earnings impacting the chip sector positively.
    *   Datavault AI's stock shifts reflecting market concerns.

*   **Analysis:** Recent news highlights the volatile nature of the AI sector. While some AI-related companies are showing positive momentum (e.g., Micron), general anxiety and concern remain. The Datavault AI article indicates specific companies within the AI space are facing market scrutiny.

**4-2) Analyst Opinions**

*   **Consensus:** Hold (Mean: 3.43)
*   **Target Price:**
    *   Average: $14.67
    *   High: $24.00
    *   Low: $8.00

*   **Analysis:** Analyst consensus is neutral, with a "Hold" rating. The wide range in target prices ($8 to $24) suggests significant uncertainty and disagreement among analysts regarding the company's future prospects.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-11-05 | 0.94 | 6.35 B$     |
| 2025-08-07 | 2    | 7.09 B$     |
| 2025-05-02 | 1.18 | 6.78 B$     |
| 2024-11-07 | 0.72 | 6.75 B$     |
| 2025-11-05 | 0.72 | 6.75 B$     |

*   **Analysis:** It is an error that dates are duplicated at 2025-11-05. There is no consistency as the revenue does not increase or decrease, so it is judged to be inconsistent.

**6) Financial Information**

*   **Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-10-31   | $0.08B  | 40.43%        |
| 2025-07-31   | $0.07B  | 37.64%        |
| 2025-04-30   | $0.11B  | 62.09%        |
| 2025-01-31   | $0.10B  | 59.07%        |
| 2024-10-31   | $0.09B  | 61.31%        |

*   **Capital and Profitability:**

| Quarter      | Equity | ROE      |
|--------------|---------|-----------|
| 2025-10-31   | $0.77B  | -13.56%   |
| 2025-07-31   | $0.80B  | -14.62%   |
| 2025-04-30   | $0.84B  | -9.51%    |
| 2025-01-31   | $0.86B  | -9.32%    |
| 2024-10-31   | $0.86B  | -7.68%    |

*   **Analysis:**
    *   Revenue fluctuates but is generally under $0.1B per quarter.
    *   Profit margins are relatively high, indicating good cost control.
    *   ROE is negative, reflecting a loss on equity. The equity is declining.

**7) Comprehensive Analysis (Summary)**

C3.ai (AI) presents a mixed picture with several concerning factors:

*   **Significant Underperformance:** The stock has drastically underperformed the S&P 500, and its relative divergence is near its historical low.
*   **Volatile Performance:** Historical data shows inconsistent growth and significant drawdowns.
*   **Downtrend:** Recent price action and technical indicators suggest a short-term downtrend.
*   **High Risk:** While the MRI suggests medium risk, the negative expected return and analyst uncertainty are cause for concern.
*   **Inconsistent Earnings:** Recent earnings per share (EPS) information is not consistent.
*   **Negative ROE:** The company is currently losing money on its equity.

**Overall Recommendation:** Based on this data, a cautious approach is warranted. The stock's recent underperformance, negative outlook, and analyst uncertainty suggest significant risk. Before considering an investment, further research and careful evaluation of the company's future prospects are strongly advised. The negative expected return and negative ROE are particularly concerning.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.